Stock Scorecard
Stock Summary for Eyenovia Inc (EYEN) - $0.51 as of 9/6/2024 3:42:48 PM EST
Total Score
4 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EYEN
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EYEN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EYEN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EYEN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for EYEN
Financial Details for EYEN
Company Overview |
|
|---|---|
| Ticker | EYEN |
| Company Name | Eyenovia Inc |
| Country | USA |
| Description | Eyenovia, Inc., a clinical-stage ophthalmic company, is dedicated to developing therapies based on its proprietary Micro-Dose Matrix Printing Platform (MAP) technology. The company is headquartered in New York, New York. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2024 |
| Next Earnings Date | 11/11/2024 |
Stock Price History |
|
| Last Day Price | 0.51 |
| Last Day Price Updated | 9/6/2024 3:42:48 PM EST |
| Last Day Volume | 1,313,161 |
| Average Daily Volume | 2,436,313 |
| 52-Week High | 2.57 |
| 52-Week Low | 0.37 |
| Last Price to 52 Week Low | 37.84% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 34.82 |
| Sector PE | 80.12 |
| 5-Year Average PE | -4.11 |
| Free Cash Flow Ratio | 17.00 |
| Industry Free Cash Flow Ratio | 13.19 |
| Sector Free Cash Flow Ratio | 30.42 |
| Current Ratio Most Recent Quarter | 0.46 |
| Total Cash Per Share | 0.03 |
| Book Value Per Share Most Recent Quarter | -0.04 |
| Price to Book Ratio | 36.17 |
| Industry Price to Book Ratio | 6.02 |
| Sector Price to Book Ratio | 22.15 |
| Price to Sales Ratio Twelve Trailing Months | 1,315.09 |
| Industry Price to Sales Ratio Twelve Trailing Months | 7.56 |
| Sector Price to Sales Ratio Twelve Trailing Months | 6.66 |
Share Statistics |
|
| Total Shares Outstanding | 76,909,000 |
| Market Capitalization | 39,223,590 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 2.50% |
| Reported EPS 12 Trailing Months | -0.78 |
| Reported EPS Past Year | -0.44 |
| Reported EPS Prior Year | -0.67 |
| Net Income Twelve Trailing Months | -37,314,533 |
| Net Income Past Year | -27,300,000 |
| Net Income Prior Year | -28,000,000 |
| Quarterly Revenue Growth YOY | 400.00% |
| 5-Year Revenue Growth | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,300,000 |
| Total Cash Past Year | 14,849,057 |
| Total Cash Prior Year | 22,863,520 |
| Net Cash Position Most Recent Quarter | -12,415,174 |
| Net Cash Position Past Year | -3,793,393 |
| Long Term Debt Past Year | 18,642,450 |
| Long Term Debt Prior Year | 8,730,772 |
| Total Debt Most Recent Quarter | 14,715,174 |
| Equity to Debt Ratio Past Year | 0.33 |
| Equity to Debt Ratio Most Recent Quarter | -0.19 |
| Total Stockholder Equity Past Year | 8,999,094 |
| Total Stockholder Equity Prior Year | 17,234,565 |
| Total Stockholder Equity Most Recent Quarter | -2,369,903 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -32,237,484 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.42 |
| Free Cash Flow Past Year | -27,807,076 |
| Free Cash Flow Prior Year | -25,645,842 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.12 |
| MACD Signal | -0.12 |
| 20-Day Bollinger Lower Band | 0.36 |
| 20-Day Bollinger Middle Band | 0.81 |
| 20-Day Bollinger Upper Band | 1.27 |
| Beta | 1.74 |
| RSI | 37.35 |
| 50-Day SMA | 1.25 |
| 150-Day SMA | 2.19 |
| 200-Day SMA | 2.93 |
System |
|
| Modified | 9/7/2024 12:51:25 AM EST |